Rochester Institute of Technology hosts AI and Data Science Summit with Vellore Institute of Technology in Chennai: Our ...

TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa: Our Bureau, Mumbai ...

Sanofi announces new Sarclisa subcutaneous formulation meets co-primary endpoints in IRAKLIA phase 3 study in multiple myeloma: Paris Friday, January 10, 2025, 15:00 Hrs [IST] Res ...

Our Bureau, Mumbai Friday, January 10, 2025, 14:45 Hrs [IST] ...

China NMPA grants expanded approval for Merck’s Gardasil for use in males 9-26 years of age to help prevent certain HPV-related cancers & diseases: Rahway, New Jersey Friday, Ja ...

Radnor, Pennsylvania Friday, January 10, 2025, 18:00 Hrs [IST] ...

Our Bureau, Mumbai Friday, January 10, 2025, 15:40 Hrs [IST] ...

IGC Pharma names IGC-AD1 phase 2 clinical trial for Alzheimer’s agitation as CALMA trial: Potomac, Maryland Friday, January 10, 2025, 16:30 Hrs [IST] IGC Pharma, Inc, an AI-powe ...

Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor: Radnor, Pennsylvania Friday, January 10, 2025 ...

Clarivate identifies eleven potential blockbuster and transformative drugs in annual Drugs to Watch report: London, UK Friday, January 10, 2025, 14:00 Hrs [IST] Clarivate Plc, a l ...

Roche’s momentum in digital pathology continues with US FDA clearance on its high-volume slide scanner: Tucson, Arizona Friday, January 10, 2025, 09:00 Hrs [IST] Roche announced ...

Our Bureau, New Delhi Friday, January 10, 2025, 16:10 Hrs [IST] ...